Delivery Order SPE2DB22D1002-SPE2DB25FLFT4
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $11,404.44 to AmerisourceBergen Drug Corp for the supply of FORTEO 560 MCG/2.24 ML pen injections on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $47,923.50 to AmerisourceBergen Drug Corp for the supply of FORTEO (560 mcg/2.24 mL pen injection), a pharmaceutical treatment for osteoporosis. The contract, awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, was issued without a set-aside designation under a firm fixed price arrangement. Performance of this delivery order will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FORTEO (Fortified Growth Factor) 560 MCG/2.24 ML pen injections on June 18, 2025, with completion targeted for June 20, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement to support federal medical supply needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,363.00 to AmerisourceBergen Drug Corp for FORTEO 560 mcg/2.24 ml pen injections. This order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed price delivery under a competitive, non-set-aside procurement. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of FORTEO (fortified with 560 mcg/2.24 mL pen injections). The contract, which became effective on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Conshohocken facility....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,982,059 units of the pharmaceutical product FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. The $11,868.34 contract has a period of performance through March 18, 2024 and is not set aside for any special designations. AmerisourceBergen Drug Corp, as the prime contractor, will deliver these pharmaceutical supplies from its corporate office...
- The Defense Logistics Agency awarded a $2,601.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 22, 2025. This non-competitive delivery order represents a single pharmaceutical procurement from the company's extensive federal contract portfolio. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- This is a $5,584.15 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the pharmaceutical product FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, and has a completion date of July 14, 2025. This order is not a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a $1,272.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty medication. The order has an ultimate completion date of January 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML pharmaceutical products. The contract has a ceiling value of $1,772.06 and a period of performance through March 15, 2024. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...